Curcumin and Tulsi For Pulmonary Disorders In Pandemic Century
Asthma, a chronic respiratory disorder, is witnessing an increasing global incidence, necessitating exploration of alternative treatments beyond conventional therapies. This study reviews the therapeutic potential of natural products, namely curcumin and tulsi, in managing asthma, juxtaposed against the backdrop of conventional pharmaceuticals. Adverse effects and limitations of current medications such as short-acting agonists, inhaled corticosteroids, and monoclonal antibodies are highlighted. Moreover, embryonic risks associated with these drugs further underscore the need for safer alternatives. Experimental findings suggest the efficacy of curcumin in reducing airway obstruction and inflammation, backed by its safety profile. Tulsi (holy basil), a mainstay in Ayurvedic treatment, also demonstrates promising effects in alleviating asthma symptoms. Future research will expand on this foundation to provide a holistic, natural treatment approach to asthma management.
Copyright (c) 2023 A Kishore Babu, Nur Azalia Rosdi, Ching Siang Tan, Bama V. V. Menon, Ganesh Sritheran Paneerselvam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:
Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.
This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.
The author(s) permits HH Publisher to publish this article that has not been submitted elsewhere.